Algert Global’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.2M | Buy |
+85,840
| New | +$1.2M | 0.03% | 765 |
|
|
2025
Q1 | – | Sell |
-39,015
| Closed | -$795K | – | 1211 |
|
|
2024
Q4 | $795K | Sell |
39,015
-9,615
| -20% | -$196K | 0.02% | 834 |
|
|
2024
Q3 | $1.42M | Buy |
48,630
+21,975
| +82% | +$640K | 0.04% | 678 |
|
|
2024
Q2 | $619K | Sell |
26,655
-55,345
| -67% | -$1.29M | 0.02% | 832 |
|
|
2024
Q1 | $1.68M | Buy |
+82,000
| New | +$1.68M | 0.07% | 468 |
|
|
2023
Q3 | – | Sell |
-16,097
| Closed | -$475K | – | 1144 |
|
|
2023
Q2 | $475K | Hold |
16,097
| – | – | 0.02% | 821 |
|
|
2023
Q1 | $371K | Sell |
16,097
-13,329
| -45% | -$307K | 0.02% | 896 |
|
|
2022
Q4 | $818K | Buy |
29,426
+21,792
| +285% | +$606K | 0.05% | 642 |
|
|
2022
Q3 | $234K | Buy |
+7,634
| New | +$234K | 0.01% | 1007 |
|
|
2022
Q2 | – | Sell |
-15,203
| Closed | -$489K | – | 1245 |
|
|
2022
Q1 | $489K | Buy |
15,203
+7,834
| +106% | +$252K | 0.03% | 820 |
|
|
2021
Q4 | $329K | Hold |
7,369
| – | – | 0.04% | 699 |
|
|
2021
Q3 | $372K | Buy |
+7,369
| New | +$372K | 0.05% | 668 |
|
|
2020
Q1 | – | Sell |
-30,974
| Closed | -$540K | – | 436 |
|
|
2019
Q4 | $540K | Buy |
+30,974
| New | +$540K | 0.16% | 196 |
|